Clinical Trial Update: Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial assessing safety and efficacy of clenbuterol in individuals with late-onset Pompe disease on enzyme replacement therapy (Phase 1/2) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Clenbuterol

Snippet

Sponsor: Dwight Koeberl, M.D., Ph.D. | Conditions: Pompe Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-23